XML 52 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Payment Arrangements (Tables)
12 Months Ended
Dec. 30, 2023
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 

 
  
Fiscal Years
 
 
  
2023
 
  
2022
 
  
2021
 
Total cost of the Plans during the period
   $ 4,282      $ 12,399      $ 27,537  
Amount of related income tax benefit recognized during the period
     (3,622      (5,199      (7,063
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 660      $
 
7,200      $
 
20,474  
    
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 

 
  
Number
of RSUs
 
  
Weighted Average

Grant Date
Fair Value
 
Outstanding at December 26, 2020
     183,213      $ 93.44  
Granted
     46,342      $ 128.64  
Shares earned in excess of target
(1)
     7,132      $ 31.97  
Vested shares, including shares earned in excess of target
     (24,600    $ 59.85  
Forfeited
     (2,688    $ 107.76  
    
 
 
          
Outstanding at December 25, 2021
     209,399      $ 102.90  
Granted
     50,019      $ 139.44  
Shares earned in excess of target
(2)
     91,497      $ 92.58  
Vested shares, including shares earned in excess of target
     (177,146    $ 95.48  
Forfeited
     (21,989    $ 113.85  
    
 
 
          
Outstanding at December 31, 2022
     151,780      $ 115.80  
Granted
     41,638      $ 164.91  
Shares earned in excess of target
(3)
     79,176      $ 98.39  
Vested shares, including shares earned in excess of target
     (137,861    $ 97.97  
Forfeited
     (2,011    $ 142.67  
    
 
 
          
Outstanding at December 30, 2023
     132,722      $ 138.93  
    
 
 
          
 
(1)
Represents shares earned in excess of target under the May 1, 2015 RSU award as total shareholder return exceeded the target under the award.
(2)
Represents additional shares earned under each of the February 2, 2017, February 2, 2018 and February 1, 2019 RSU awards, as fiscal year 2021 financial results exceeded target performance level under each such award.
(3)
Represents additional shares earned (i) under the February 1, 2019 and January 31, 2020 RSU awards as fiscal year 2022 financial results exceeded target performance level and (ii) under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 

 
  
Number of

Shares and Deferred

Stock Units
 
  
Weighted Average
Grant Date

Fair Value
 
Non-vested
at December 26, 2020
     60,440      $ 103.65  
Granted
     26,351      $ 150.20  
Vested
     (29,055    $ 104.35  
Forfeited
     (1,300    $ 97.81  
    
 
 
          
Non-vested
at December 25, 2021
     56,436      $ 125.16  
Granted
     25,354      $ 152.54  
Vested
     (27,074    $ 122.68  
Forfeited
     (6,921    $ 144.45  
    
 
 
          
Non-vested
at December 31, 2022
     47,795      $ 138.30  
Granted
     22,714      $ 179.32  
Vested
     (24,161    $ 138.35  
    
 
 
          
Non-vested
at December 30, 2023
     46,348      $ 158.38  
    
 
 
          
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Options Outstanding
    
Options Exercisable
 
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
 
Options at December 26, 2020
     17,650      $ 54.16        17,650      $ 54.16  
Exercised
     (9,080    $ 52.97                    
    
 
 
                            
Options at December 25, 2021
     8,570      $ 55.42        8,570      $ 55.42  
Exercised
     (6,670    $ 55.14                    
    
 
 
                            
Options at December 31, 2022
     1,900      $ 56.40        1,900      $ 56.40  
Exercised
     (1,900    $ 56.40                    
    
 
 
                            
Options at December 30, 2023
     —                  —